ARQT
Arcutis Biotherapeutics, Inc.C5415-min delayed · EOD close23.85 +0.42% upas of 2026-09-02mkt cap $3.0B
Pharmaceutical Preparations · SIC 2834 · CIK 0001787306
Income statement
| Metric | Value | Period | Source |
|---|---|---|---|
| Revenue | $464M | 2026-06-30 | 10-Q · 0001787306-26-000051 |
| Revenue (prior year) | $197M | 2024-12-31 | 10-K · 0001787306-25-000029 |
| Operating income | $34.3M | 2026-06-30 | 10-Q · 0001787306-26-000051 |
| Net income | $28.5M | 2026-06-30 | 10-Q · 0001787306-26-000051 |
Balance sheet
| Metric | Value | Period | Source |
|---|---|---|---|
| Total assets | $489M | 2026-06-30 | 10-Q · 0001787306-26-000051 |
| Current assets | $468M | 2026-06-30 | 10-Q · 0001787306-26-000051 |
| Total liabilities | $268M | 2026-06-30 | 10-Q · 0001787306-26-000051 |